- Barry Silbert discusses new secondary markets for private companies and other alternative assets (link)
- Burrill Report – growth in drug sales slows (link)
- Gates Foundation funding many ‘Out of the Box’ ideas (link)
- Growing your biotech startup through mergers (link)
- Academic biases and Biotech failures (link)
Required Reading – Secondary Markets, Slowing Drug Growth, Gates, Startup Mergers, etc.
Previous post: Pacific Biosciences – An Inside Look